Side N
Small Variants in the Long-Read Era
Which sources back which section of this article, and what its evidence base looks like.
Which sources back which section
| Section | Sources behind it |
|---|---|
| What happened | The review, read in full, and its Crossref record for the publication date. |
| Timeline | The review’s reference list for each year, with the T2T, pangenome and clinical-validation papers checked at PubMed. |
| The argument | The review, set against the T2T paper’s own description of the 8%. |
| What others add | The review’s strategy comparison and Table 1, with the pangenome figure checked against the HPRC paper. |
| Conclusion | The review’s conclusions, and the clinical validation paper for what is settled. |
What the evidence base looks like
- 5Sources used on the page
- 1Read in full: the review itself
- 3Cited papers read at their PubMed abstracts to check a figure
| Function | How many | What they are |
|---|---|---|
| Reference | 5 | A peer-reviewed review, its registry record, and three peer-reviewed papers it cites. |
| State | 0 | None. |
| Vendor | 0 | None. No sequencing company’s own claim is used. |
| Origin | 0 | None. |
| Reporting | 0 | None. Nothing on the page rests on a news report. |
| Community | 0 | None. |
Reliable
Reliable, but with an interestWorth believing and reliableWeak on both, and used with careHonest, but thin
Worth believing